{"err":null,"data":[{"categories":["research-chemical","nootropic"],"dose_note":"Rapid onset.","formatted_aftereffects":{"_unit":"hours","value":"1-4"},"formatted_dose":{"Oral":{"Common":"1500mg"}},"formatted_duration":{"_unit":"hours","value":"2-4"},"links":{"experiences":"https://www.erowid.org/experiences/subs/exp_Aniracetam.shtml"},"name":"aniracetam","pretty_name":"Aniracetam","properties":{"after-effects":"1-4 hours.","bioavailability":"Oral: 8.6-11.4% (This is due to the extensive first pass hepatic metabolism) Presumably higher when taken with fatty acids.","categories":["research-chemical","nootropic"],"dose":"Oral Common: 1500mg","duration":"2-4 hours.","summary":"An anxiolytic nootropic which modulates the AMPA receptor. Significantly more potent than racetam. May have positive effects on memory and cognition. Little recreational value. Sold in Europe as a prescription drug, but not approved by the FDA in the US."}}]}